EUVIMEDEUVIMED entdecken
Crossref

Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1

Mingyu Han, Jianning Yang, Pingting Chen, Sui Li, Hailin Tang, Huali Fan, Yuhan Wang, Xue Li, Weiwei Pan, Vasili Koutouratsas, Zijin Zhao, Fu Peng

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Mingyu Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Pharmacy, Sichuan University, Chengdu, 610041, China; Department of Neurosurgery, Xiangya Hospital, Central South University, Ch…. Hauptthemen laut MEDLINE: Caveolin 1, Anoikis, Glioma, Triterpenes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, China Association for Science and Technology, State Administration of Traditional Chinese Medicine of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas, known for their aggressive nature, high recurrence rates, and resistance to conventional therapies, require the development of novel treatment strategies. This study emphasizes the critical role of caveolin 1 (CAV1) in glioma progression and highlights the potent anti-glioma effects of isocucurbitacin B. The compound effectively inhibits glioma cell proliferation, invasion, migration, and epithelial-mesenchymal transition, while also inducing G2/M phase arrest and promoting apoptosis. Further analysis revealed that isocucurbitacin B promotes anoikis, a form of cell death induced by detachment, by downregulating CAV1. Notably, isocucurbitacin B directly binds to CAV1, confirmed by cellular thermal shift assays and microscale thermophoresis, positioning CAV1 as a key therapeutic target. Additionally, isocucurbitacin B activates the BKCa calcium channel, resulting in increased intracellular Ca2+ and reduced pH, establishing a novel connection between calcium dynamics and anoikis. Overexpression of CAV1 inhibited anoikis, blocking apoptosis and promoting migration, while decreased CAV1 expression facilitated anoikis and significantly reduced glioma cell proliferation and motility. In vivo experiments using zebrafish patient-derived xenografts and orthotopic glioblastoma models further demonstrated that isocucurbitacin B effectively suppresses tumor growth by downregulating CAV1. These findings underscore the multifaceted anti-glioma potential of isocucurbitacin B and highlight CAV1 as a crucial mediator of anoikis and a promising therapeutic target in glioma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caveolin 1AnoikisGliomaTriterpenesBrain NeoplasmsHumansAnimalsZebrafishCell Line, TumorCell ProliferationCell MovementXenograft Model Antitumor AssaysEpithelial-Mesenchymal TransitionApoptosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AnoikisCETSACaveolin 1GlioblastomaIsocucurbitacin BOrthotopic glioma mouse modelPDX model

Substanzen

Caveolin 1TriterpenesCAV1 protein, humancucurbitacin B

Autor:innen und Institutionen

  • West China School of Pharmacy, Sichuan University, Chengdu, 610041, China; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410043, China; National Clinical Research Center for Geriatric…
  • West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
  • West China School of Pharmacy, Sichuan University, Chengdu, 610041, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center,…
  • West China School of Pharmacy, Sichuan University, Chengdu, 610041, China; Waigaoqiao Free Trade Zone, WuXi Biologics, Shanghai, 214122, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Department of Cell Biology, College of Medicine, Jiaxing University, 118 Jiahang Road, Jiaxing, 314001, China.

Förderung

  • Science and Technology Department of Sichuan Province
  • China Association for Science and Technology
  • State Administration of Traditional Chinese Medicine of the People's Republic of China
  • Sichuan Provincial Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • National Adminstration of Traditional Chinese Medicine
  • Sichuan University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Han, M., Yang, J., Chen, P., Li, S., Tang, H., Fan, H., Wang, Y., Li, X., Pan, W., Koutouratsas, V., Zhao, Z., & Peng, F. (2025). Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217873

Vancouver

Han M, Yang J, Chen P, Li S, Tang H, Fan H, et al. Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217873

BibTeX
@article{Han2025,
  author = {Han, Mingyu and Yang, Jianning and Chen, Pingting and Li, Sui and Tang, Hailin and Fan, Huali and Wang, Yuhan and Li, Xue and Pan, Weiwei and Koutouratsas, Vasili and Zhao, Zijin and Peng, Fu},
  title = {Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217873}
}
Kostenlos starten →